Hegyi Péter Jenő, Szakács Zsolt, Faluhelyi Nándor, Németh Balázs Csaba, Bajor Judit, Hegyi Péter
Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary; Szentágothai Research Center, University of Pécs, Pécs, Hungary.
Pancreatology. 2020 Dec;20(8):1656-1660. doi: 10.1016/j.pan.2020.10.026. Epub 2020 Oct 10.
Drug-induced acute pancreatitis (DIAP) is an often-neglected entity where the disorder is the consequence of the toxic effects of various agents applied to treat potentially life-threatening conditions, such as inflammatory bowel disease. Here, we present the case of a male patient with ulcerative colitis with a history of two episodes of recurrent acute pancreatitis. After excluding other potential causes, we suspected DIAP since the patient received 5-aminosalycilate (5-ASA) prior to the first episode and, one year later, azathioprine (AZA) prior to the second episode. The causative effect of AZA was confirmed by performing a re-challenge with a reduced dose. While both episodes of DIAP had a mild disease course, they were associated with acute relapse of ulcerative colitis. Last seen, the patient was asymptomatic. With this case, we would like to highlight the importance and diagnostic difficulties of DIAP in the background of recurrent cases when common etiological factors of acute pancreatitis are excluded.
药物性急性胰腺炎(DIAP)是一种常被忽视的疾病,该病症是用于治疗潜在危及生命状况(如炎症性肠病)的各种药物产生毒性作用的结果。在此,我们报告一例患有溃疡性结肠炎的男性患者,其有两次复发性急性胰腺炎发作史。在排除其他潜在病因后,我们怀疑是DIAP,因为该患者在首次发作前接受了5-氨基水杨酸(5-ASA)治疗,一年后,在第二次发作前接受了硫唑嘌呤(AZA)治疗。通过降低剂量进行再激发试验证实了AZA的致病作用。虽然DIAP的两次发作病程均较轻,但均与溃疡性结肠炎的急性复发相关。最后一次就诊时,患者无症状。通过这个病例,我们想强调在排除急性胰腺炎常见病因的复发病例背景下DIAP的重要性和诊断困难。